Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia

53Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fumarylacetoacetate fumarylhydrolase (E.C.3.7.I.2.), a liver enzyme involved in tyrosine degradation, is shown to be present in many human tissues and cells including lymphocytes, fibroblasts, and cultured amniotic fluid cells. The enzyme activity in lymphocytes from six patients with hereditary tyrosinemia (hepatorenal type) and fibroblasts from three patients, was found to be less than 10% of the activity in control subjects. In lymphocytes and fibroblasts from the parents (n = 16) of the patients the enzyme values were compatible with a heterozygote genotype. The lymphocyte enzyme pattern of the control subjects (n = 97), is complicated, and indicates possible enzyme variants. © 1983 International Pediatric Research Foundation, Inc.

Cite

CITATION STYLE

APA

Kvittingen, E. A., Halvorsen, S., & Jellum, E. (1983). Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia. Pediatric Research, 17(7), 541–544. https://doi.org/10.1203/00006450-198307000-00005

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free